Eastwood Bio-Medical Canada Inc. Announces Over One Hundred Eleotin Discussion Groups

Dec 19, 2018

Eastwood Bio-Medical Canada Inc. Begins Commercial Production of Natural Statin Product

Dec 18, 2018

Naturally Splendid Provides Expanded Distribution Update of HempOmega™ Infused Beers

Dec 13, 2018

Naturally Splendid Receives NATERA FX™ Purchase Order for Pharmacy Chain

Dec 10, 2018

Naturally Splendid To Vigorously Defend Action

Dec 7, 2018

Naturally Splendid Appoints Compounding Pharmacist, Bob Mehr, to Advisory Board for NateraFX™

Dec 5, 2018

Eastwood Bio-Medical Canada Settles Loan Owed by Eastwood Bio-Medical Research Inc.

Nov 28, 2018

Naturally Splendid Secures National Distribution for Pawsitive FX™ Pet Product Line

Nov 27, 2018

Naturally Splendid Reports Third Quarter Results for 2018

Nov 22, 2018

Naturally Splendid and Wahupta Ventures Inc. Complete Further Financings and Proceed with Processing License

Nov 22, 2018

Eastwood Bio-Medical Canada Inc. Announces Unaudited Quarterly Revenue Estimates

Nov 15, 2018

Naturally Splendid Provides HempOmega® Highlights

Nov 8, 2018

Naturally Splendid First Tranche of Wahupta Investment Commitment Completed

Oct 25, 2018

Naturally Splendid Announces Proprietary HempOmega™ Approved for Hemp Fortified Beer Formulations and Commences Production

Oct 24, 2018

Naturally Splendid Appoints Dr. Lorne Swetlikoff to Advisory Board as Medical Advisor

Oct 19, 2018

Naturally Splendid Launches NATERA FX(TM) for Practitioner Market Secures $500,000 CDN Commitment

Oct 18, 2018

Eastwood Bio-medical Canada Inc. Unaware Of Any Material Change for Immediate Release

Oct 18, 2018

Wahupta Ventures Inc. Enters Into Hemp Food Market with Naturally Splendid Enterprises Ltd. Agreement

Oct 17, 2018

Life Science